Clinical social work and the biomedical industrial complex

Journal of Sociology and Social Welfare

Volumn 38, Issue 4, 2011, Pages 135-165

  Gomory, Tomi ^a   Wong, Stephen E ^b   Cohen, David ^b   Lacasse, Jeffrey R ^c  

^a FLORIDA STATE UNIVERSITY   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Clinical social work; Mental health; Pharmaceutical; Psychiatry; Social welfare

Indexed keywords

EID: 81555205625     PISSN: 01915096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Abbott, A. D. (1988). The system of professions: An essay on the division of expert labor. Chicago, IL: The University of Chicago Press.
2. Albee, G. W., & Gullotta, T. P. (Eds.). (1997). Primary prevention works. Thousand Oaks, CA: Sage.
3. Alexander, L. B. (1972). Social work's Freudian deluge: Myth or reality? Social Service Review, 46, 517-538.
4. Ammerman, R. T., & Hersen, M. (Eds.). (1997). Handbook of prevention and treatment with children and adolescents. New York, NY: John Wiley & Sons.
5. Andreasen, N. C. (2007). DSM and the death of phenomenology in America: An example of unintended consequences. Schizophrenia Bulletin, 33, 108-112.
6. Austrian, S. G. (2005). Mental disorders, medications, and clinical social work (3rd ed.). New York, NY: Columbia University Press.
7. Bentley, K. J., & Walsh, J. F. (2006). The social worker and psychotropic medications: Toward effective collaboration with mental health clients, families, and providers (3rd ed.). Belmont, CA: Thomson Brooks/Cole.
8. Bielefeld, W., & Chu, J. (2010). Foundations and social welfare in the twentieth century. In H. K. Anheier & D. C. Hammack (Eds.), American foundations: Roles and contributions (pp. 158-181). Washington, DC: The Brookings Institution.
9. Blair, A. (1992). The role of primary prevention in mental health services: A review and critique. Journal of Community & Applied Social Psychology, 2, 77-94
10. Bola, J. R., & Mosher, L. R. (2003). Treatment of acute psychosis without neuroleptics: Two-year outcomes from the Soteria Project. Journal of Nervous and Mental Disease, 191, 219-229.
11. Bola, J. R., Mosher, L. R., & Cohen, D. (2005). Treatment of newly diagnosed psychosis without antipsychotic drugs: The Soteria Project. In S. A. Kirk (Ed.), Mental disorders in the social environment: Critical perspectives (pp. 368-384). New York, NY: Columbia University Press.
12. Bond, G. R., Drake, R. E., Mueser, K. T., & Latimer, E. (2001). Assertive community treatment: Critical ingredients and impact on patients. Disease Management and Health Outcomes, 9(3), 141-159.
13. Bourdon, K. H., Rae, D. S., Narrow, W. E., Manderscheid, R. W., & Regier, D. A. (1994). National prevalence and treatment of mental and addictive disorders. In R. W. Manderscheid & M. A. Sonnenschein (Eds.), Mental health, United States, 1994 (pp. 22-51). Washington, DC: Superintendent of Documents, U.S. Government Printing Office.
14. Boyle, M. (2002). Schizophrenia: A scientific delusion? (2nd ed.). London: Routledge.
15. Bradshaw, W. (2003). Use of single-system research to evaluate the effectiveness of cognitive-behavioural treatment of schizophrenia. British Journal of Social Work, 33, 885-899.
16. Bradshaw, W., & Roseborough, D. (2004). Evaluating the effectiveness of cognitive-behavioral treatment of residual symptoms and impairment in schizophrenia. Research in Social Work Practice, 14(2), 112-120.
17. Breggin, P. R. (1997). Brain disabling treatments in psychiatry: Drugs, electroshock, and the role of the FDA. New York, NY: Springer.
18. Brody, J. (2007). Hooked: Ethics, the medical profession and the pharmaceutical industry. Lanham, MD: Rowman and Littlefield.
19. California Health & Human Services Agency. (2009). Involuntary detention data: Fiscal year 2006-07. CA: California Health and Human Services Agency, Department of Mental Health.
20. Caplan, P. J. (1995). They say you're crazy: How the world's most powerful psychiatrists decide who's normal. Boston, MA: Perseus.
21. Caplan, P. J., & Cosgrove, L. (Eds.). (2004). Bias in psychiatric diagnosis. New York, NY: Jason Aronson.
22. Carpenter, M. (2001). It's a small world: Mental health policy under welfare capitalism since 1945. In J. Busfield (Ed.), Rethinking the sociology of mental health (pp. 58-75). Oxford: Blackwell.
23. Cassels, A. (2009). Ponziceuticals within the medical industrial complex. Canadian Medical Association Journal, 181, 1-2.
24. Christy, A. (2007). The Florida Mental Health Act (Baker Act) 2007 annual report. Tampa, FL: Louis de la Parte Florida Mental Health Institute, University of South Florida.
25. Clark, E. (2007, May). Social work must be at the table. NASW News, 54(5), 3.
26. Cohen, D. (2002). Research on the drug treatment of schizophrenia: A critical appraisal and implications for social work education. Journal of Social Work Education, 38, 217-239.
27. Cohen, D. (2010). Psychopharmacology and clinical social work practice. In J. R. Brandell (Ed.), Theory and practice of clinical social work (2nd ed., pp. 763-810). Newbury Park, CA: Sage.
28. Cohen, D., and 19 signatories. (2007). Open letter to NASW regarding "Adherence Initiative for Schizophrenia." Retrieved from www.manufacturedconsensus.net.
29. Conrad, P. (2007). The medicalization of society: On the transformation of human conditions into treatable disorders. Baltimore, MD: Johns Hopkins University Press.
30. Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L. (2006). Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychotherapy and Psychosomatics, 75, 154-160.
31. Dolnick, E. (1998). Madness on the couch: Blaming the victim in the heyday of psychoanalysis. New York, NY: Simon & Schuster.
32. Duhl, L. J., Cummings, N. A., & Hynes, J. J. (1987). The emergence of the mental health complex. In L. J. Duhl & N. A. Cummings (Eds.), The future of mental health services: Coping with crisis (pp. 1-14). New York, NY: Springer.
33. Dyer, O. (2007). Lilly investigated in US over the marketing of olanzapine. BMJ (What does this stand for?), 334, 171.
34. Dziegielewski, S. F., & Leon, A. M. (2001). Social work practice and psychopharmacology. New York, NY: Springer.
35. Eack, S. M., Greenwald, D. P., Hogarty, S. S., Cooley, S. J., DiBarry, A. L., Montrose, D. M., & Keshavan, M. S. (2009). Cognitive enhancement therapy for early-course schizophrenia: Effects of a two-year randomized controlled trial. Psychiatric Services, 60(11), 1468-1476.
36. Feeley, J., & Fisk, M. C. (2010, October 14). Johnson and Johnson must pay Louisiana $257.7 million over Risperdal marketing practices. Bloomberg News. Retrieved October 18, 2010 from http://tinyurl.com/26awovg.
37. Fenton, W. S., Mosher, L. R., Herrell, J. M., & Blyler, C. R. (1998). Randomized trial of general hospital and residential alternative care for patients with severe and persistent mental illness. American Journal of Psychiatry, 155, 516-522.
38. Feinberg, M. E., Jones, D., Greenberg, M. T., Osgood, D. W., & Bontempo, D. (2010). Effects of the Communities That Care Model in Pennsylvania on change in adolescent risk and problem behaviors. Prevention Science, 11, 163-171.
39. Florida Department of Children and Families. (2009). Report of Gabriel Myers workgroup. Retrieved May 28, 2010 from http://www.dcf.state.fl.us/initiatives/GMWorkgroup/docs/GabrielMyersWorkGroupReport082009Final.pdf.
40. Frances, A. (2009, June 26). A warning sign on the road to DSM-V: Beware of its unintended consequences. Psychiatric Times, 1-6.
41. Fraser, M. W., Day, S. H., Galinsky, M., Hodges, V., & Smokowski, P. R. (2004). Preventing youth violence: A single-blind, randomized trial of a multi-element program for aggressive, rejected children in elementary school. Research on Social Work Practice, 13, 1-22.
42. Frazer, P., Westhuis, D., Daley, J. G., & Phillips, I. (2009). How clinical social workers are using the DSM-IV: A national study. Social Work in Mental Health, 7, 325-339.
43. Gollaher, D. (1995). Voice for the mad: The life of Dorothea Dix. New York, NY: The Free Press.
44. Gomory, T. (2005). Assertive community treatment (ACT): The case against the "best tested" evidence-based community treatment for severe mental illness. In S. A. Kirk (Ed.), Mental disorders in the social environment: Critical perspectives (pp. 165-189). New York, NY: Columbia University Press.
45. Greenfield, T. K., Stoneking, B. C., Humphreys, K., Sundby, E., & Bond, J. (2008). A randomized trial of a mental health consumermanaged alternative to civil commitment for acute psychiatric crisis. American Journal of Community Psychology, 42, 135-144.
46. Grob, G. N. (1973). Mental institutions in America: Social policy to 1875. New York, NY: The Free Press.
47. Grob, G. N. (1994). The mad among us: A history of America's mentally ill. Cambridge, MA: Harvard University Press.
48. Haggerty, K. P., Skinner, M. L., MacKenzie, E. P., & Catalano, R. F. (2007). A randomized trial of Parents Who Care: Effects on key outcomes at 24-month follow-up. Prevention Science, 8, 249-260.
49. Harris, G. (2009, October 21). Drug makers are advocacy group's biggest donors. New York Times. Retrieved from: http://www.nytimes.com/2009/10/22/health/22nami.html.
50. Hawkins, J. D., Oesterle, S., Brown, E. C., Arthur, M. W., Abbott, R. D., Fagan, A. A., & Catalano, R. F. (2009). Results of a type 2 translational research trial to prevent adolescent drug use and delinquency. Archives of Pediatrics & Adolescent Medicine, 163(9), 789-798.
51. Healy, D. (2006). Manufacturing consensus. Culture, Medicine and Psychiatry, 30(2), 135-156.
52. Healy, D. (2008). Mania: A short history of bipolar disorder. Baltimore, MD: Johns Hopkins University Press.
53. Hollingshead, A. d. B., & Redlich, F. C. (1958). Social class and mental illness: A community study. New York, NY: Wiley.
54. Hudson, C. G. (2005). Socioeconomic status and mental illness: Tests of the social causation and selection hypotheses. American Journal of Orthopsychiatry, 75, 3-18.
55. Huston, P., & Moher, D. (1996). Redundancy, disaggregation, and the integrity of medical research. Lancet, 347, 1024-1026.
56. Hutchinson, E. D. (1992). Competing moral values and use of social work authority with involuntary clients. In P. N. Reid & P. R. Popple (Eds.), The moral purposes of social work: The character and intentions of a profession (pp. 120-140). Chicago, IL: Nelson-Hall Inc.
57. Jacobs, D. H., & Cohen, D. (2004). Hidden in plain sight: DSM-IV's rejection of the categorical approach to diagnosis. Review of Existential Psychology & Psychiatry, 26(2-3), 81-96.
58. Jacobs, D. H., & Cohen, D. (2010). Does "psychological dysfunction" mean anything? A critical essay on pathology vs. agency. Journal of Humanistic Psychology, 50, 312-334.
59. Jones, P. B., Barnes, T. R., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K. P., et al. (2006). Randomized controlled trial of the effect on quality of life of second- vs. first-generation antipsychotic drugs in schizophrenia: Cost utility of the latest antipsychotic drugs in schizophrenia study (CUTLASS-1). Archives of General Psychiatry, 63, 1079-1087.
60. Kiesler, C. A., & Sibulkin, A. E. (1987). Mental hospitalization: Myths and facts about a national crisis. Newbury Park, CA: Sage.
61. Kiesler, C. A., & Simpkins, C. G. (1993). The unnoticed majority in psychiatric inpatient care. New York, NY: Plenum.
62. Kirk, S. A., & Kutchins, H. (1988). Deliberate misdiagnosis in mental health practice. Social Service Review, 62, 225-237.
63. Kirk, S. A., & Kutchins, H. (1992). The selling of DSM: The rhetoric of science in psychiatry. New York, NY: Aldine De Gruyter.
64. Kirk, S. A., & Kutchins, H. (1994). The myth of the reliability of DSM. Journal of Mind and Behavior, 15(1&2), 71-86.
65. Kirk, S. A., Siporin, M., & Kutchins, H. (1989). The prognosis for social work diagnosis. Social Casework, 70(5), 295-304.
66. Klerman, G. (1978). The evolution of a scientific nosology. In J.C. Shershaw (Ed.), Schizophrenia: Science and practice (pp. 99-121). Cambridge, MA: Harvard University Press.
67. Kmietowicz, Z. (2009). Eli Lilly pays record $1.4bn for promoting off-label use of olanzapine. British Medical Journal, 338, b217.
68. Kupfer, D. J., First, M. B., & Regier, D. A. (2002). A research agenda for DSM-V. Washington, DC: American Psychiatric Association.
69. Lacasse, J. R. (2005). Consumer advertising of psychiatric medications biases the public against non-pharmacological treatment. Ethical Human Psychology and Psychiatry, 7, 175-179.
70. Lacasse, J. R., & Gomory, T. (2003). Is graduate social work education promoting a critical approach to mental health practice? Journal of Social Work Education, 39, 383-408.
71. Lecroy, C. W. (2004a). Evaluation of an empowerment program for early adolescent girls. Adolescence, 39, 427-441.
72. Lecroy, C. W. (2004b). Experimental evaluation of "Go Grrrls" preventive intervention for early adolescent girls. Journal of Primary Prevention, 25, 457-473.
73. Leiby, J. (1978). A history of social welfare and social work in the United States. New York, NY: Columbia University Press.
74. Levit, K. R., Kassed, C. A., Coffey, R. M., Mark, T. L., Stranges, E. M., Buck, J. A., & Vandivort-Warren, R. (2008). Future funding for mental health and substance abuse: Increasing burdens for the public health sector. Health Affairs, 27(6), w513-w522.
75. Lieberman, J. A. (2006). Comparative effectiveness of antipsychotic drugs. Archives of General Psychiatry, 63, 1069-1072.
76. Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M.S., Rosenheck, R. A., Perkins, D.O., et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209-1223.
77. Lightner, D. L. (1999). Asylum, prison, and poor house: The writing and reform work of Dorothea Dix in Illinois. Carbondale, IL: Southern Illinois University Press.
78. Lloyd-Evans, B., Slade, M., Jagielska, D., & Johnson, S. (2009). Residential alternatives to acute psychiatric hospital admission: Systematic review. British Journal of Psychiatry, 195, 109-117.
79. Lubove, R. (1983). The professional altruist. New York, NY: Atheneum. (Original work published 1965).
80. Lynch, D., Laws, K. R., & McKenna, P. J. (2010). Cognitive behavioural therapy for major psychiatric disorder: Does it really work? A meta-analytical review of well-controlled trials. Psychological Medicine, 40, 9-24.
81. Manderscheid, R. W., & Berry, J. T. (Eds.). (2006). Mental Health, United States, 2004. Rockville, MD: Substance Abuse and Mental Health Services Administration.
82. Margolin, L. (1997). Under the cover of kindness: The invention of social work. Charlottesville, VA: University Press of Virginia.
83. Mechanic, D. (1990). Deinstitutionalization: An appraisal of reform. Annual Review of Sociology, 16, 301-327.
84. Mirowsky, J., & Ross, C. E. (2003). Social causes of psychological distress (2nd ed.). New York, NY: Walter de Gruyter.
85. Moncrieff, J. (2008). The myth of the chemical cure: A critique of psychiatric drug treatment. New York, NY: Palgrave MacMillan.
86. Moynihan, R., & Cassels, A. (2005). Selling sickness. Vancouver, BC: Douglas & McIntyre.
87. Murray, T. L. (2009). The loss of client agency into the psychopharmaceutical-industrial complex. Journal of Mental Health Counseling, 31, 283-408.
88. National Association of Social Workers. (2005). NASW standards for clinical social work in social work practice. Washington, DC: Author.
89. Olsen, D. P. (2000). Policy implications of the biological model of mental disorder. Nursing Ethics, 7, 412-424.
90. Pam, A. (1990). A critique of the scientific status of biological psychiatry. Acta Psychiatrica Scandinavica, 82(Suppl. 362), 1-35.
91. Pam, A. (1995). Biological psychiatry: Science or pseudoscience? In C. A. Ross & A. Pam (Eds.), Pseudoscience in biological psychiatry (pp. 7-84). New York, NY: John Wiley & Sons.
92. Pfeiffer, S. I. (1990). An analysis of methodology in follow-up studies of adult inpatient psychiatric treatment. Hospital and Community Psychiatry, 41, 1315-1321.
93. Pilling, S., Bebbington, P., Kuipers, E., Garety, P., Geddes, J., Orbach, G., & Morgan, C. (2002). Psychological treatments in schizophrenia: Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine, 32, 763-782.
94. Pottick, K., Hansell, S., Gaboda, D., & Gutterman, E. (1993). Child and adolescent outcomes of inpatient psychiatric services: A research agenda. Children and Youth Services Review, 15, 371-384.
95. Read, J., Mosher, L., & Bentall, R. (Eds). (2004). Models of madness: Psychological, social, and biological approaches to schizophrenia. New York, NY: Brunner-Routledge.
96. Read, J., van Os, J., Morrison, A. P., & Ross, C. A. (2005). Childhood trauma, psychosis and schizophrenia: A literature review with theoretical and clinical implications. Acta Psychiatrica Scandinavica, 112, 330-350.
97. Reamer, F. G. (1992). Social work and the public good: Calling or career? In P. N. Reid & P. R. Popple (Eds.), The moral purposes of social work: The character and intentions of a profession (pp. 11-33). Chicago: Nelson-Hall Inc.
98. Reid, P. N. (1992). The social function and social morality of social work: A utilitarian perspective. In P. N. Reid & P. R. Popple (Eds.), The moral purposes of social work: The character and intentions of a profession (pp. 34-50). Chicago: Nelson-Hall Inc.
99. Reeser, L. C., & Leighninger, L. (1990). Back to our roots: Toward a specialization in social justice. Journal of Sociology and Social Welfare, 17(2), 69-87.
100. Relman, A. S. (1980). The new medical-industrial complex. New England Journal of Medicine, 303, 963-970.
101. Richmond, M. (1917). Social diagnosis. New York, NY: Russell Sage Foundation.
102. Rothman, D. J. (1990). The discovery of the asylum. Boston, MA: Little, Brown.
103. Rosenheck, R. A., Leslie, D. L., & Doshi, J. A. (2008). Second-generation antipsychotics: Cost effectiveness, policy options, and political decision making. Psychiatric Services, 59, 515-520.
104. Scull, A. (1981). Madhouses, mad-doctors, and madmen: The social history of psychiatry in the Victorian era. Philadelphia, PA: University of Pennsylvania Press.
105. Seikkula, J., Alakre, B., Aaltonen, J., Holma, J., Rasinkangas, A., & Lehtinen, V. (2003). Open dialogue approach: Treatment principles and preliminary results of a two-year follow-up on first-episode schizophrenia. Ethical Human Sciences and Services, 5(3), 163-182.
106. Seikkula, J., Aaltonen, J., Alakare, B., Haarakangas, K., Keranen, J., & Lehtinen, K. (2006). Five-year experience of first-episode nonaffective psychosis in open-dialogue approach: Treatment principles, follow-up outcomes, and two case studies. Psychotherapy Research, 16(2), 214-228.
107. Sledge, W. H., Tebes, J., Rakfeldt, J., Davidson, L., Lyons, L., & Druss, B. (1996). Day hospital/crisis respite care versus inpatient care, Part I: Clinical outcomes. American Journal of Psychiatry, 153, 1065-1073.
108. Smith, S. R. (2010). The political economy of contracting and competition. In Y. Hasenfeld (Ed.), Human services as complex organizations (2nd ed., pp. 139-160). Thousand Oaks, CA: Sage.
109. Tanne, J. H. (2010). AstraZeneca pays $520m fine for off label marketing. British Medical Journal, 340, c2380.
110. Trattner, W. I. (1979). From poor law to welfare state: A history of social welfare in America (2nd ed.). New York, NY: Free Press.
111. Tucker, G. J. (1998). Putting DSM-IV in perspective. American Journal of Psychiatry, 155, 159-161.
112. Turnock, B. J. (2009). Public health: What it is and how it works (4th ed). Boston: Jones & Bartlett.
113. Umberson, D., & Montez, J. K. (2010). Social relationships and health: A flashpoint for health policy. Journal of Health and Social Behavior, 51, S54-S66.
114. United States Bureau of Labor Statistics. (2010). Occupational outlook handbook, 2010-2011 edition. Retrieved October 10, 2010, from http://www.bls.gov/oco/ocos060.htm.
115. Valenstein, E. S. (1998). Blaming the brain: The truth about drugs and mental health. New York, NY: The Free Press.
116. Walsh, J., Green, R., Matthews, J., & Bonucelli-Puerto, B. (2005). Social workers' views of the etiology of mental disorders: Results of a national study. Social Work, 50, 43-52.
117. Waters, R. (2007, September 27). Lilly's Zyprexa poised for approval for U.S. teens. Bloomberg News. Retrieved from http://www.bloomberg.com.
118. Wen, P. (2010, January 21). Social worker warned that Rebecca Riley, 4, was overmedicated. Boston Globe. Retrieved May 28, 2010 from http://www.boston.com/news/local/breaking_news/2010/01/social_worker_w.html.
119. Whitaker, R. (2002). Mad in America. Cambridge, MA: Perseus Publishing.
120. Whitaker, R. (2010). Anatomy of an epidemic: Magic bullets, psychiatric drugs, and the astonishing rise of mental illness in America. New York, NY: Crown.
121. Whitaker, T., & Arrington, P. (2008). Professional development. NASW Membership Workforce Study. Washington, DC: National Association of Social Workers.
122. Wilson, D. (2009, December 12). Poor children likelier to get antipsychotics. New York Times, A1.
123. Wong, S. E. (1996). Psychosis. In M. Mattaini & B. A. Thyer (Eds.), Finding solutions to social problems: Behavioral strategies for change (pp. 319-343). Washington, DC: American Psychological Association.
124. Wong, S. E. (2006). Behavior analysis of psychotic disorders: Scientific dead end or casualty of the mental health political economy? Behavior and Social Issues, 15, 152-177.
125. Wong, S. E. (2007, May). Psychotropic meds [Letter to the Editor]. NASW News, 54(5), 3.
126. Wong, S. E., Wilder, D. A., Schock, K., & Clay, C. (2004). Behavioral interventions with severe and persistent mental disorders. In H. E. Briggs & T. L. Rzepnicki (Eds.), Using evidence in social work practice: Behavioral perspectives (pp. 210-230). Chicago, IL: Lyceum Books.
127. Wykes, T., Steel, C., Everitt, B., & Tarrier, N. (2008). Cognitive behavior therapy for schizophrenia: Effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin, 34(3), 523-527.
128. Zito, J. M., Safer, D. J., Devadatta, S., Gardner, J. F., Thomas, D., Coomges, P., Dubowski, M. & Medez-Lewis, M. (2008). Psychotoropic medication patterns among youth in foster care. Pediatrics, 121, e157-e163.